Cargando…

Affective disorders: the role of the duration of untreated illness, suicidality and pharmacogenetics

Detalles Bibliográficos
Autores principales:	Falkai, P., Möller, H.-J.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911536/ https://www.ncbi.nlm.nih.gov/pubmed/20668979 http://dx.doi.org/10.1007/s00406-010-0128-8

Ejemplares similares

Pain, affect and psychotic illness
por: Möller, H.-J., et al.
Publicado: (2011)

Individuals with untreated psychiatric disorders and suicide in the COVID-19 era
por: Sher, Leo
Publicado: (2020)

Duration of untreated illness of patients with obsessive–compulsive disorder in Japan
por: Matsumoto, Yoshihiro, et al.
Publicado: (2020)

Comorbidities, Depression Severity, and Circadian Rhythms Disturbances as Clinical Correlates of Duration of Untreated Illness in Affective Disorders
por: Menculini, Giulia, et al.
Publicado: (2021)

Duration of untreated illness in panic disorder: a poor outcome risk factor?
por: Altamura, A Carlo, et al.
Publicado: (2005)

Emotional status: diagnosis and treatment for severe psychiatric disorders
por: Falkai, P., et al.
Publicado: (2011)

Mood disorders in the light of genes, comorbidity and contemporary treatment
por: Falkai, P., et al.
Publicado: (2011)

Correlates of long duration of untreated illness (DUI) in patients with bipolar disorder: results of an observational study
por: Di Salvo, Gabriele, et al.
Publicado: (2023)

Duration of untreated bipolar disorder: a multicenter study
por: Zhang, Ling, et al.
Publicado: (2017)

Understanding mental disorders from neuronal networks to glial cells and proteomics
por: Falkai, Peter, et al.
Publicado: (2010)

Duration of Untreated Illness in Patients with Obsessive–Compulsive Disorder and Its Impact on Long-Term Outcome: A Systematic Review
por: Perris, Francesco, et al.
Publicado: (2023)

Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy
por: Falkai, P., et al.
Publicado: (2010)

Achievement and maintenance of the new impact factor 2010
por: Falkai, P., et al.
Publicado: (2011)

The psychosis continuum: diagnosis and other phenotypes
por: Möller, H. J., et al.
Publicado: (2011)

From generation of biomarkers to treatment and psychosocial aspects of psychosis
por: Falkai, P., et al.
Publicado: (2011)

Neurobiology of schizophrenia: from outcome to pathophysiological insights
por: Falkai, P., et al.
Publicado: (2012)

The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction
por: Falkai, P., et al.
Publicado: (2011)

Examining evidence for neighbourhood variation in the duration of untreated psychosis
por: Kirkbride, J.B., et al.
Publicado: (2010)

PT621. Difference of visual spatial dysfunction in drug naïve obsessive compulsive disorder patients in association of untreated duration of illness
por: Kim, Sung Nyun, et al.
Publicado: (2016)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Short-term Clinical Outcome of Previously Untreated and Treated Schizophrenia and Impact of Duration of Untreated Psychosis
por: Bansal, Priyanka, et al.
Publicado: (2023)

Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi
por: Myaba, Japhet, et al.
Publicado: (2021)

Sleep, hypothalamus, and stigma
por: Falkai, Peter, et al.
Publicado: (2010)

Psychopathology: genetics and the stress-vulnerability hypothesis
por: Falkai, Peter, et al.
Publicado: (2012)

From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits
por: Falkai, Peter, et al.
Publicado: (2012)

Biomarkers and neurobiology of schizophrenia
por: Falkai, Peter, et al.
Publicado: (2012)

Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review
por: Möller, Hans-Jürgen, et al.
Publicado: (2023)

The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders
por: Albert, Nikolai, et al.
Publicado: (2017)

Suicide Risk and Mental Disorders
por: Brådvik, Louise
Publicado: (2018)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020)

“Pharmacogenetics of Cancer” - Cancer Drug Resistance special issue
por: Mini, Enrico, et al.
Publicado: (2020)

Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022)

Suicide among untreated and treated depressives: the role of compliance, drug-resistance and underlying bipolarity
por: Rihmer, Zoltan
Publicado: (2010)

Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders
por: Berendsen, Steven, et al.
Publicado: (2020)

Affected neural networks as basis of disturbed motor function in schizophrenia
por: Schmitt, Andrea, et al.
Publicado: (2020)

Pathways to Care: Duration of Untreated Psychosis from Karachi, Pakistan
por: Naqvi, Haider A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_eafeasijh9cet4jc9uf3b97e6m